Literature DB >> 26023237

Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia.

Egle Jakubauskiene1, Laurynas Vilys1, Yuichi Makino2, Lorenz Poellinger3, Arvydas Kanopka4.   

Abstract

The removal of introns from mRNA precursors (pre-mRNAs) is an essential step in eukaryotic gene expression. The splicing machinery heavily contributes to biological complexity and especially to the ability of cells to adapt to altered cellular conditions. Inhibitory PAS domain protein (IPAS), a dominant negative regulator of hypoxia-inducible gene expression, is generated from hypoxia inducible transcription factor-3α (HIF-3α) pre-mRNA by an alternative splicing mechanism. Inactivation of the IPAS transcript in mice leads to the neo-vascularization of the cornea, suggesting that IPAS is an important regulator of anti-angiogenesis in this tissue. For the first time we demonstrate that serine-arginine (SR) proteins are involved in oxygen tension-dependent changes in pre-mRNA splicing. SR proteins isolated from hypoxic cells differentially interact with RNA (compared with proteins isolated from cells cultured under normoxic conditions). They possess the differential ability to activate hypoxia-dependent splice sites, and they are more phosphorylated than those isolated from normoxic HeLa cells. We also show that expression of SR protein kinases (CLK1, SRPK1, SRPK2) in hypoxic cells is elevated at mRNA and protein levels. Increased expression of CLK1 kinase is regulated by HIFs. Reduction of CLK1 cellular expression levels reduces hypoxia-dependent full-length carbonic anhydrase IX (CAIX) mRNA and CAIX protein formation and changes hypoxia-dependent cysteine-rich angiogenic inducer 61 (Cyr61) mRNA isoform formation profiles.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  RNA splicing; alternative splicing; hypoxia; phosphorylation; serine/threonine protein kinase; spliceosome

Mesh:

Substances:

Year:  2015        PMID: 26023237      PMCID: PMC4505053          DOI: 10.1074/jbc.M115.639690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Alternative pre-mRNA splicing: the logic of combinatorial control.

Authors:  C W Smith; J Valcárcel
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

Review 2.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Hypoxia regulates alternative splicing of HIF and non-HIF target genes.

Authors:  Johnny A Sena; Liyi Wang; Lynn E Heasley; Cheng-Jun Hu
Journal:  Mol Cancer Res       Date:  2014-05-21       Impact factor: 5.852

4.  Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.

Authors:  Jacky Chi Ki Ngo; Sutapa Chakrabarti; Jian-Hua Ding; Adolfo Velazquez-Dones; Brad Nolen; Brandon E Aubol; Joseph A Adams; Xiang-Dong Fu; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2005-10-07       Impact factor: 17.970

5.  The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing.

Authors:  J Prasad; K Colwill; T Pawson; J L Manley
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Regulation of alternative splicing by the core spliceosomal machinery.

Authors:  Arneet L Saltzman; Qun Pan; Benjamin J Blencowe
Journal:  Genes Dev       Date:  2011-02-15       Impact factor: 11.361

7.  Processive phosphorylation of alternative splicing factor/splicing factor 2.

Authors:  Brandon E Aubol; Sutapa Chakrabarti; Jacky Ngo; Jennifer Shaffer; Brad Nolen; Xiang-Dong Fu; Gourisankar Ghosh; Joseph A Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

8.  Manipulation of alternative splicing by a newly developed inhibitor of Clks.

Authors:  Michiko Muraki; Bisei Ohkawara; Takamitsu Hosoya; Hiroshi Onogi; Jun Koizumi; Tomonobu Koizumi; Kengo Sumi; Jun-ichiro Yomoda; Michael V Murray; Hiroshi Kimura; Kiyoshi Furuichi; Hiroshi Shibuya; Adrian R Krainer; Masaaki Suzuki; Masatoshi Hagiwara
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

Review 9.  Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology.

Authors:  Gregg L Semenza
Journal:  Annu Rev Pathol       Date:  2013-08-07       Impact factor: 23.472

10.  Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array.

Authors:  Xingyi Hang; Peiyao Li; Zhifeng Li; Wubin Qu; Ying Yu; Hualing Li; Zhiyong Shen; Hao Zheng; Yan Gao; Yonghong Wu; Minghua Deng; Zhixian Sun; Chenggang Zhang
Journal:  BMC Genomics       Date:  2009-03-25       Impact factor: 3.969

View more
  19 in total

Review 1.  Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige.

Authors:  Subhashis Natua; Cheemala Ashok; Sanjeev Shukla
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

2.  Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth.

Authors:  Chao Li; Lv-Jie Xu; Wen-Wen Lian; Xiao-Cong Pang; Hao Jia; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2018-05-25       Impact factor: 6.150

Review 3.  Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!

Authors:  Sónia C Correia; Paula I Moreira
Journal:  Cell Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.046

Review 4.  Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics.

Authors:  Qiu Peng; Yujuan Zhou; Linda Oyang; Nayiyuan Wu; Yanyan Tang; Min Su; Xia Luo; Ying Wang; Xiaowu Sheng; Jian Ma; Qianjin Liao
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

Review 5.  Alternative Splicing and Hypoxia Puzzle in Alzheimer's and Parkinson's Diseases.

Authors:  Eglė Jakubauskienė; Arvydas Kanopka
Journal:  Genes (Basel)       Date:  2021-08-20       Impact factor: 4.096

6.  Genetic variants of the hypoxia-inducible factor 3 alpha subunit (Hif3a) gene in the Fat and Lean mouse selection lines.

Authors:  Špela Mikec; Martin Šimon; Nicholas M Morton; Santosh S Atanur; Janez Konc; Peter Dovč; Simon Horvat; Tanja Kunej
Journal:  Mol Biol Rep       Date:  2022-03-26       Impact factor: 2.742

7.  Alternative splicing is a Sorghum bicolor defense response to fungal infection.

Authors:  Lanxiang Wang; Moxian Chen; Fuyuan Zhu; Tao Fan; Jianhua Zhang; Clive Lo
Journal:  Planta       Date:  2019-11-27       Impact factor: 4.116

Review 8.  Signaling Pathways Driving Aberrant Splicing in Cancer Cells.

Authors:  Vânia Gonçalves; Joana F S Pereira; Peter Jordan
Journal:  Genes (Basel)       Date:  2017-12-29       Impact factor: 4.096

9.  MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Authors:  Qiuran Xu; Xin Liu; Zhikui Liu; Zhenyu Zhou; Yufeng Wang; Jianfeng Tu; Lijie Li; Hangxing Bao; Liu Yang; Kangsheng Tu
Journal:  Mol Cancer       Date:  2017-06-12       Impact factor: 27.401

10.  Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation.

Authors:  Lauren K Brady; Hejia Wang; Caleb M Radens; Yue Bi; Milan Radovich; Amit Maity; Cristina Ivan; Mircea Ivan; Yoseph Barash; Constantinos Koumenis
Journal:  PLoS Biol       Date:  2017-09-29       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.